Table 9.
Phenotypic characteristics of human HPCs in comparison with described markers in publications
| Reference | Positive | Negative |
|---|---|---|
| Dan et al. 31 | CK18, CK19, CD34, CD90, CD117, EpCAM, Vimentin c-Met, SSEA-4 | ALB, AFP |
| Herrera et al. 30 | CK8, CK18, CD29, CD44, CD73, CD90, Vimentin, Nestin, ALB, AFP | CK19, CD34, CD45, CD117, CD133 |
| Schmelzer et al. 32 | CK19, NCAM, EpCAM, CLDN3, ALB (low) | AFP |
| Duret et al. 33 | CK7, CK18, CK19, ALB (low), AAT | REX1, AFP, CD34, CD90, CD117, OV-6 |
| Terrace et al. 34 | CK18, CK19, CD34, CD90, ALB, E-cadherin, dlk/pref-1, Vimentin | |
| Stachelscheid et al. 35 | CK7, CK8, CK18, CK19, EpCAM, Vimentin, CYP2B6, ALB (intermediate), A1AT (intermediate), γ-GT, HNF4 (low) | AFP, CD90 |
| Jozefczuk et al. 36 | CK7, CK8, CK18, CK19, CD24, CD133, EpCAM, Vimentin, CYP1B1, ABCC4, ANXA3, ANXA1, CLDN4, DDR1, GABRP, ITGB4, MUC1, S100A3, ALB (intermediate), A1AT (intermediate), HNF4 (low) | AFP, CD90 |
| Li, et al. (this study) | CK8, CK18, CK19, CD45, CD90, CD109, CD117, OV-6, ALB, AFP, PTX3, COL5A2, COL1A1, EFEMP1, DKK3, ACTA2, SLC16A4, TPBG, MAP1B, GJA1, CYBRD1, BCAT1, ARMCX2, SPARC, ID4, PROCR, PDGFD, COL4A2, TIMP2, PAM | CD24, CD34, CD44, CD99, CD200, D320, TAT, GS, G6PD |